Schlagwort: licensing
Part II: The Best Asset Doesn’t Have a Passport
For many years, Western biotech companies viewed China primarily as a manufacturing base and, increasingly, as an attractive commercial market. Today, that perspective is...
The Biotech IP Flip: Scaling Up Instead of Selling
Many European biotech companies still view the U.S. market primarily as a future exit channel. Yet it can be leveraged much earlier - not...
‘‘We build a leading global platform for precision healthcare‘‘
Leo International Precision Health AG (LIPH) is an investment holding company (WKN: 549060; ticker: LEOW) that has been listed on the stock exchange since...